Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2methylphenyl)carbonyl]amino}-3-methylphenyl )acetic acid

Details for Australian Patent Application No. 2009256688 (hide)

Owner Glaxo Group Limited

Inventors Keel, Trevor Raymond; Vallance, Sarah

Agent Davies Collison Cave

Pub. Number AU-A-2009256688

PCT Pub. Number WO2009/150118

Priority 0810615.5 10.06.08 GB

Filing date 8 June 2009

Wipo publication date 17 December 2009

International Classifications

C07C 215/10 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

A61K 31/195 (2006.01)

A61K 31/205 (2006.01)

A61P 19/00 (2006.01) Drugs for skeletal disorders

C07C 235/56 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/150118 Priority application(s): WO2009/150118

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009256689-Novel polymorphic forms of (4-{[(5-{[ (3-chlorophenyl)methyl]oxy}-2-methylph enyl) carbonyl]amino}-3-methylphenyl)acetic acid

2009256680-Pyrrolidine ether derivatives as NK3 receptor antagonists